VC Fundraising Fell In Q4 But There Are Glimmers Of Hope For 2024

Quality Of Top Five Financings Bodes Well

 
• By Mandy Jackson

Evaluate’s fourth quarter data show that biopharma venture capital fundraising fell from $4.28bn in in Q3, but there was a rise in smaller deals and financial market conditions are poised for a turnaround.

Internet, business, Technology and network concept. Venture capital. Investor capital.
Q4 VC funding fell from Q3, but smaller deals rebounded • Source: Shutterstock

More from Financing

More from Business